74 results
Page 3 of 4
DEF 14A
lp97j8nl3wkq vtcf
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
73esaht 0143oc
14 Apr 20
Preliminary proxy
4:46pm
10-K
EX-10.16
mqj80tyio5758
27 Feb 20
Annual report
4:02pm
10-K
EX-10.15
hvw7ul90eeef2v7au3k
27 Feb 20
Annual report
4:02pm
10-K
EX-10.13
4rx4w5syhamfxt08had8
27 Feb 20
Annual report
4:02pm
10-K
EX-10.14
n7o9bdd
27 Feb 20
Annual report
4:02pm
10-K
b8i j2c9mmj9g
27 Feb 20
Annual report
4:02pm
6-K
EX-99.1
tn37ub
6 Nov 19
Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting
4:07pm
6-K
EX-99.1
n5uq5ow
30 Jul 19
Three-Year Registrational Data Set to be Presented by Year End 2019
4:00pm
424B4
2iq6jr6v21ij143v0n2i
6 Jun 19
Prospectus supplement with pricing info
4:28pm
F-1
4lq80
3 Jun 19
Registration statement (foreign)
4:33pm
DRS
rpb6 j0rk0c8hr
3 May 19
Draft registration statement
12:00am
20-F/A
EX-4.12
7o9uht chju
26 Apr 19
Annual report (foreign) (amended)
4:54pm
6-K
EX-99.1
7m3fy2dvfs8tqj0rd
25 Apr 19
Program on Track for MAA and BLA Regulatory Submissions in 2021
4:00pm
20-F
EX-4.12
q5qmpplb
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-4.3
dravc 17d1y1q6wc4
22 Mar 19
Annual report (foreign)
8:02am
20-F
fvr 4q617i
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-1.1
kqwf b273
22 Mar 19
Annual report (foreign)
8:02am
6-K
EX-99.1
bdjp2by qtwzyuywz
25 Feb 19
Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID
12:00am
424B4
pavh6w 98
31 Oct 18
Prospectus supplement with pricing info
4:36pm